Aindo

Aindo builds a platform that generates synthetic datasets replicating the statistical characteristics of real tabular data, intended to enable data sharing and analysis while preserving privacy. The company originated from the International School for Advanced Studies (SISSA) in Trieste and applies its technology to healthcare use cases, including analysis of pharmacological therapies for rare diseases. Aindo was founded in 2018 and raised a €6M Series A round in 2023 led by United Ventures.